USA 111 , 91639168 (2014)
some peptide-industry sources report a Pharmacy Compounding Advisory Committee review was scheduled for July 2026 that could revisit this status, but that outcome had not been independently confirmed as of this writing
The BPC-157 athletic performance benefit comes from reduced soft-tissue downtime, not from any direct anabolic action
HSS journal : the musculoskeletal journal of Hospital for Special Surgery , 21 (4), 15563316251355551
declares having received consulting honoraria from Novo Nordisk, Eli Lilly, Boehringer Ingelheim and AstraZeneca, and received research grants through his affiliation from Novo Nordisk, Eli Lilly, Boehringer Ingelheim and Rhythm
That's BPC-157